FDA Inspection 914387 — Centaur Pharmaceuticals Private Ltd.

Centaur Pharmaceuticals Private Ltd. — FEI 3003973520

The FDA completed an inspection of Centaur Pharmaceuticals Private Ltd. on February 5, 2015 in Thane. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 5, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Thane (India)